Dec 04, 2018 - Incyte (INCY) announces positive data on lead drug Jakafi at the ASH meet for the indication of acute GVHD.
Nov 19, 2018 - AstraZeneca (AZN) announced that Imfinzi as a monotherapy or in combination with tremelimumab failed to improve overall survival in first-line NSCLC. The combination had also failed to improve progression free survival last year.
Nov 12, 2018 - Merck's (MRK) Keytruda gains FDA approval for hepatocellular carcinoma (HCC) in patients previously treated with sorafenib.
Oct 30, 2018 - INCY earnings call for the period ending September 30, 2018.
Oct 30, 2018 -
Oct 24, 2018 - Earnings releases and key data-read outs were the key developments in the biotech sector last week.
Sep 29, 2018 - A disappointing decision could mean one fewer competitor for these biotech companies.
Sep 13, 2018 - Merck's (MRK) sBLA to include overall survival data from a key lung cancer study on Keytruda's label gets FDA's priority review. If approved, it will expand the eligible patient population.
Sep 12, 2018 - Pipeline updates and collaborating agreement comprise some of the key developments in the biotech sector this week.
Sep 12, 2018 - Incyte (INCY) inks an agreement with Foundation Medicine for the development of companion diagnostics (CDx) for Incy's selective FGFR Inhibitor, pemigatinib.